Literature DB >> 15183904

Management of Jehovah's Witness patients with haematological problems.

Michael J Nash1, Hannah Cohen.   

Abstract

The management of practising Jehovah's Witnesses who have haematological problems presents many different challenges both at the level of treatment strategy and ethics. This article focuses on the beliefs of Jehovah's Witnesses and addresses treatment modalities available for and acceptable to these individuals. Recent advances in the development of novel therapeutic agents have aided the management of Jehovah's Witnesses. Finally, the background to the ethical dilemmas raised by these issues is discussed.

Entities:  

Keywords:  Health Care and Public Health; Religious Approach

Mesh:

Year:  2004        PMID: 15183904     DOI: 10.1016/S0268-960X(03)00065-1

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  2 in total

1.  Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma.

Authors:  Judit Demeter; Ildiko Istenes; Anikó Fodor; Melinda Paksi; Peter Dombi; Erika Valasinyószki; Judit Csomor; András Matolcsy; Zsolt G Nagy
Journal:  Pathol Oncol Res       Date:  2010-07-14       Impact factor: 3.201

Review 2.  Ethical and deontological issues in Transfusion Medicine.

Authors:  Dario Sacchini; Giancarlo Maria Liumbruno; Gennaro Bruno; Chiara Liumbruno; Daniela Rafanelli; Roberta Minacori; Pietro Refolo; Antonio G Spagnolo
Journal:  Blood Transfus       Date:  2012-09-19       Impact factor: 3.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.